Jianmin Pharmaceutical Group Co Ltd (600976) — Financial Flexibility Index
Jianmin Pharmaceutical Group Co Ltd (600976) has a Financial Flexibility Index of 0.07x as of December 2025. Free cash flow of CN¥130.05 Million (operating CF CN¥106.82 Million minus capex CN¥23.23 Million) represents 0% of total liabilities (CN¥1.81 Billion). Also explore Jianmin Pharmaceutical Group Co Ltd (600976) equity growth momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Jianmin Pharmaceutical Group Co Ltd Financial Flexibility Index (2003–2025)
Historical Financial Flexibility Index trend for Jianmin Pharmaceutical Group Co Ltd across 23 annual periods. Check 600976 capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Jianmin Pharmaceutical Group Co Ltd (2003–2025)
Year-by-year free cash flow to debt coverage for Jianmin Pharmaceutical Group Co Ltd. For the full company profile including market capitalisation, see market cap of Jianmin Pharmaceutical Group Co Ltd.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.21x | CN¥375.20 Million | CN¥274.53 Million | CN¥1.81 Billion | ▲ +7.1% |
| 2024 | 0.19x | CN¥354.55 Million | CN¥234.27 Million | CN¥1.83 Billion | ▲ +11.4% |
| 2023 | 0.17x | CN¥332.89 Million | CN¥268.39 Million | CN¥1.91 Billion | ▼ -3.7% |
| 2022 | 0.18x | CN¥283.83 Million | CN¥215.87 Million | CN¥1.57 Billion | ▼ -27.9% |
| 2021 | 0.25x | CN¥315.17 Million | CN¥259.18 Million | CN¥1.26 Billion | ▲ +60.2% |
| 2020 | 0.16x | CN¥171.12 Million | CN¥125.54 Million | CN¥1.09 Billion | ▼ -21.6% |
| 2019 | 0.20x | CN¥143.76 Million | CN¥74.45 Million | CN¥720.63 Million | ▲ +8.7% |
| 2018 | 0.18x | CN¥105.97 Million | CN¥63.60 Million | CN¥577.11 Million | ▲ +94.4% |
| 2017 | 0.09x | CN¥77.13 Million | CN¥35.20 Million | CN¥816.71 Million | ▼ -48.8% |
| 2016 | 0.18x | CN¥143.26 Million | CN¥113.84 Million | CN¥776.45 Million | ▲ +42.7% |
| 2015 | 0.13x | CN¥78.20 Million | CN¥48.45 Million | CN¥604.72 Million | ▼ -45.8% |
| 2014 | 0.24x | CN¥130.00 Million | CN¥103.23 Million | CN¥544.79 Million | ▲ +74.0% |
| 2013 | 0.14x | CN¥69.26 Million | CN¥45.36 Million | CN¥504.92 Million | ▼ -54.2% |
| 2012 | 0.30x | CN¥107.14 Million | CN¥98.17 Million | CN¥357.90 Million | ▲ +230.0% |
| 2011 | -0.23x | CN¥-67.09 Million | CN¥-75.54 Million | CN¥291.28 Million | ▼ -133.9% |
| 2010 | 0.68x | CN¥155.49 Million | CN¥150.08 Million | CN¥228.78 Million | ▲ +298.3% |
| 2009 | 0.17x | CN¥81.19 Million | CN¥66.69 Million | CN¥475.79 Million | ▼ -42.9% |
| 2008 | 0.30x | CN¥118.79 Million | CN¥110.11 Million | CN¥397.80 Million | ▲ +1313.5% |
| 2007 | 0.02x | CN¥3.02 Million | CN¥-6.88 Million | CN¥143.07 Million | ▼ -91.7% |
| 2006 | 0.26x | CN¥72.79 Million | CN¥56.18 Million | CN¥285.18 Million | ▲ +577.2% |
| 2005 | -0.05x | CN¥-16.12 Million | CN¥-34.63 Million | CN¥301.33 Million | ▼ -119.0% |
| 2004 | 0.28x | CN¥61.78 Million | CN¥4.13 Million | CN¥219.38 Million | ▼ -33.2% |
| 2003 | 0.42x | CN¥102.07 Million | CN¥4.19 Million | CN¥242.31 Million | — |